Table 3 AMR analysis results from two different platform sequencing data sets
From: Identification of pathogens in culture-negative infective endocarditis cases by metagenomic analysis
Drug | Platform | Sample ID | |||
|---|---|---|---|---|---|
A1 | A2 | A5 | A7 | ||
Tetracycline | BGI | – | tetM | tetM | tetM |
Nanopore | – | – | – | tetM | |
Macrolide | BGI | – | ErmB,RlmA(II) | ErmB,RlmA(II) | ErmB |
Nanopore | – | – | ErmB | ErmB | |
Lincosamide | BGI | – | ErmB,RlmA(II) | ErmB,RlmA(II) | ErmB |
Nanopore | – | – | ErmB | ErmB | |
Streptogramin | BGI | – | ErmB | ErmB | ErmB |
Nanopore | – | – | ErmB | ErmB | |
Fluoroquinolone | BGI | – | patB | patB,pmrA | – |
Nanopore | – | – | – | – | |